SNAI1 enhances production of C-C motif chemokine ligand (CCL) 2, which can subsequently induce EMT signaling in other cells of tumor microenvironment (TME) lacking endogenous SNAI1 while simultaneously contributing to the development of immunoregulatory DC populations. The gene discussed is SNAI1; the disease is neoplasm.